Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Roche Holding AG : Close to an important medium term support level

08/19/2020 | 03:09am EDT
long trade
Target price hit
Entry price : 315.8CHF | Target : 328CHF | Stop-loss : 307CHF | Potential : 3.86%
The medium term support area around 309.7 CHF should allow Roche Holding AG shares to re-establish an upward trend in the short term.
Investors have an opportunity to buy the stock and target the CHF 328.
Roche Holding AG : Roche Holding AG : Close to an important medium term support level
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at CHF 308.7 CHF in weekly data.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the CHF 309.7 support.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 308.7 CHF

Weaknesses
  • The company's earnings releases usually do not meet expectations.
  • With an enterprise value anticipated at 4.29 times the sales for the current fiscal year, the company turns out to be overvalued.

ę MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2021 61 371 M 66 361 M 66 361 M
Net income 2021 14 747 M 15 945 M 15 945 M
Net cash 2021 4 289 M 4 637 M 4 637 M
P/E ratio 2021 19,8x
Yield 2021 2,76%
Capitalization 298 B 322 B 322 B
EV / Sales 2021 4,78x
EV / Sales 2022 4,61x
Nbr of Employees 101 465
Free-Float 83,5%
Upcoming event on ROCHE HOLDING AG
09/28/21
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 340,40 CHF
Average target price 382,65 CHF
Spread / Average Target 12,4%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
AndrÚ S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG10.16%321 605
JOHNSON & JOHNSON4.44%432 675
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037
ABBVIE INC.-0.07%189 211